日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

The effects of interleukin-6-receptor inhibition on monocytes in STEMI: a substudy of the ASSAIL-MI trial.

白细胞介素-6受体抑制对STEMI患者单核细胞的影响:ASSAIL-MI试验的子研究。

Huse Camilla, Murphy Sarah Louise, Yang Kuan, Balzer Nora Reka, Stokke Mathis K, Anstensrud Anne Kristine, Bjerkeli Vigdis, Rentz Thiago, Jha Prabhash Kumar, Ugland Hege Katrin, Michelsen Annika E, Ueland Thor, Holm Sverre, Tøllefsen Ingvild Maria, Bendz Bjørn, Kleveland Ola, Andersen Geir Øystein, Gullestad Lars, Louch William E, Woxholt Sindre, Osnes Liv, Broch Kaspar, Ulas Thomas, Aukrust Pål, Libby Peter, Halvorsen Bente, Dahl Tuva B

The N-6 methyladenosine dynamics in STEMI and the effect of IL-6 inhibition - a hypothesis generating sub-study of the ASSAIL-MI trial

STEMI 中 N-6 甲基腺苷的动态变化及 IL-6 抑制剂的作用——ASSAIL-MI 试验的一项假设生成性子研究

Dahl, Tuva B; Quiles-Jiménez, Ana; Broch, Kaspar; Anstensrud, Anne Kristine; Gullestad, Lars; Andersen, Geir Ø; Kleveland, Ola; Øgaard, Jonas; Bjerkeli, Vigdis; Rashidi, Azita; Yang, Kuan; Holven, Kirsten B; Aukrust, Pål; Bjørås, Magnar; Huse, Camilla; Halvorsen, Bente

Proteogenomic Data Integration Reveals CXCL10 as a Potentially Downstream Causal Mediator for IL-6 Signaling on Atherosclerosis

蛋白质组学数据整合揭示 CXCL10 可能是 IL-6 信号通路在动脉粥样硬化中的潜在下游因果介质

Prapiadou, Savvina; Živković, Luka; Thorand, Barbara; George, Marc J; van der Laan, Sander W; Malik, Rainer; Herder, Christian; Koenig, Wolfgang; Ueland, Thor; Kleveland, Ola; Aukrust, Pål; Gullestad, Lars; Bernhagen, Jürgen; Pasterkamp, Gerard; Peters, Annette; Hingorani, Aroon D; Rosand, Jonathan; Dichgans, Martin; Anderson, Christopher D; Georgakis, Marios K

Cytokine pattern in patients with ST-elevation myocardial infarction treated with the interleukin-6 receptor antagonist tocilizumab

接受白细胞介素-6受体拮抗剂托珠单抗治疗的ST段抬高型心肌梗死患者的细胞因子模式

Woxholt, Sindre; Ueland, T; Aukrust, Pål; Anstensrud, Anne Kristine; Broch, Kaspar; Tøllefsen, Ingvild Maria; Ryan, Liv; Bendz, Bjørn; Hopp, Einar; Kløw, Nils-Einar; Seljeflot, Ingebjørg; Halvorsen, Bente; Dahl, Tuva B; Huse, Camilla; Andersen, Geir Øystein; Gullestad, Lars; Wiseth, Rune; Amundsen, Brage H; Damas, Jan Kristian; Kleveland, Ola

Proteogenomic integration reveals CXCL10 as a potentially downstream causal mediator for IL-6 signaling on atherosclerosis

蛋白质基因组整合揭示CXCL10可能是IL-6信号通路在动脉粥样硬化中的潜在下游因果介质

Prapiadou, Savvina; Živković, Luka; Thorand, Barbara; George, Marc J; van der Laan, Sander W; Malik, Rainer; Herder, Christian; Koenig, Wolfgang; Ueland, Thor; Kleveland, Ola; Aukrust, Pal; Gullestad, Lars; Bernhagen, Jürgen; Pasterkamp, Gerard; Peters, Annette; Hingorani, Aroon D; Rosand, Jonathan; Dichgans, Martin; Anderson, Christopher D; Georgakis, Marios K

Interleukin-6 inhibition in ST-elevation myocardial infarction: Immune cell profile in the randomised ASSAIL-MI trial

ST段抬高型心肌梗死中白细胞介素-6抑制:随机ASSAIL-MI试验中的免疫细胞谱

Huse, Camilla; Anstensrud, Anne Kristine; Michelsen, Annika E; Ueland, Thor; Broch, Kaspar; Woxholt, Sindre; Yang, Kuan; Sharma, Kapil; Tøllefsen, Ingvild Maria; Bendz, Bjørn; Amundsen, Brage Høyem; Damås, Jan Kristian; Berg, Erlend Sturle; Bjørkelund, Elisabeth; Quiles-Jiménez, Ana; Bjerkeli, Vigdis; Bendz, Christina; Kleveland, Ola; Stensaeth, Knut Haakon; Opdahl, Anders; Kløw, Nils-Einar; Andersen, Geir Øystein; Wiseth, Rune; Halvorsen, Bente; Gullestad, Lars; Seljeflot, Ingebjørg; Aukrust, Pål; Osnes, Liv; Dahl, Tuva B

Tocilizumab increases citrullinated histone 3 in non-ST segment elevation myocardial infarction

托珠单抗可增加非ST段抬高型心肌梗死患者体内瓜氨酸化组蛋白3的水平

Helseth, Ragnhild; Kleveland, Ola; Ueland, Thor; Wiseth, Rune; Damas, Jan Kristian; Broch, Kaspar; Michelsen, Annika; Bendz, Bjørn; Gullestad, Lars; Aukrust, Pål; Seljeflot, Ingebjørg

Novel Insights Into the Effects of Interleukin 6 Antagonism in Non-ST-Segment-Elevation Myocardial Infarction Employing the SOMAscan Proteomics Platform.

利用 SOMAscan 蛋白质组学平台对白细胞介素 6 拮抗剂在非 ST 段抬高型心肌梗死中的作用进行新的研究

George Marc J, Kleveland Ola, Garcia-Hernandez Jorge, Palmen Jutta, Lovering Ruth, Wiseth Rune, Aukrust Pål, Engmann Jorgen, Damås Jan Kristian, Hingorani Aroon D, Gullestad Lars, Casas Juan P, Ueland Thor

Rationale for the ASSAIL-MI-trial: a randomised controlled trial designed to assess the effect of tocilizumab on myocardial salvage in patients with acute ST-elevation myocardial infarction (STEMI)

ASSAIL-MI试验的理由:一项随机对照试验,旨在评估托珠单抗对急性ST段抬高型心肌梗死(STEMI)患者心肌挽救的效果。

Anstensrud, Anne Kristine; Woxholt, Sindre; Sharma, Kapil; Broch, Kaspar; Bendz, Bjørn; Aakhus, Svend; Ueland, Thor; Amundsen, Brage H; Damås, Jan Kristian; Hopp, Einar; Kleveland, Ola; Stensæth, Knut Haakon; Opdahl, Anders; Kløw, Nils-Einar; Seljeflot, Ingebjørg; Andersen, Geir Øystein; Wiseth, Rune; Aukrust, Pål; Gullestad, Lars

IL-6 Receptor Inhibition by Tocilizumab Attenuated Expression of C5a Receptor 1 and 2 in Non-ST-Elevation Myocardial Infarction

托珠单抗抑制IL-6受体可减弱非ST段抬高型心肌梗死中C5a受体1和2的表达

Orrem, Hilde L; Nilsson, Per H; Pischke, Søren E; Kleveland, Ola; Yndestad, Arne; Ekholt, Karin; Damås, Jan K; Espevik, Terje; Bendz, Bjørn; Halvorsen, Bente; Gregersen, Ida; Wiseth, Rune; Andersen, Geir Ø; Ueland, Thor; Gullestad, Lars; Aukrust, Pål; Barratt-Due, Andreas; Mollnes, Tom E